News | RIVM

Seasonal flu epidemic in the Netherlands

The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.

Flu epidemic seems to be emerging

More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.

RIVM calls for increased involvement of scientific community in solving plastic crisis

Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

Vaccination coverage increases for second consecutive year, by 10% for HPV

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

Het aantal jonge vrouwen dat zich laat vaccineren tegen HPV is toegenomen met 10%

Flu jab for additional groups

The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons

Method for safe and sustainable recycling of waste

The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.

Last winter’s flu epidemic was short and mild. And then COVID-19 arrived.

The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.

De griepepidemie in de winter van 2019/2020 was mild en duurde slechts 5 weken.

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

More children vaccinated against mumps, measles, rubella and HPV

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.